Benjamin Kann, MD (IMAGE)

ECOG-ACRIN Cancer Research Group

Benjamin Kann, MD

Caption

"This type of research is key since it can help identify patients with high-risk, aggressive head and neck cancer, and also help select appropriate patients for therapy de-escalation," says Dr. Benjamin Kann, who led the study.

Credit

Artificial Intelligence in Medicine Program, Brigham and Women's Hospital

Usage Restrictions

No restrictions.

License

Public Domain

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.